Literature DB >> 2851450

Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.

C Wilson1, M C Coldwell, D R Howlett, S M Cooper, T C Hamilton.   

Abstract

Three agents with K+ channel blocking activity, procaine, 4-aminopyridine (4-AP) and tetraethylammonium (TEA), were tested for inhibition of vasorelaxation and 86Rb+ efflux induced by cromakalim (BRL 34915), pinacidil and nicorandil in rabbit isolated mesenteric artery. The potency order for inhibition of vasorelaxation was procaine greater than 4-AP greater than TEA and for inhibition of efflux was procaine = 4-AP greater than TEA. The K+ channel blockers did not discriminate between cromakalim, pinacidil or nicorandil on efflux but demonstrated preferential inhibition of vasorelaxation to cromakalim greater than pinacidil greater than nicorandil. In addition, the maximum response to cromakalim was depressed but that to pinacidil and nicorandil was not. The results confirm the role of K+ channel activation in vasorelaxation to cromakalim, pinacidil and nicorandil, but suggest that additional mechanisms may be involved for pinacidil and, in particular, for nicorandil.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851450     DOI: 10.1016/0014-2999(88)90728-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Pinacidil activates the ATP-sensitive K+ channel in inside-out and cell-attached patch membranes of guinea-pig ventricular myocytes.

Authors:  Z Fan; K Nakayama; M Hiraoka
Journal:  Pflugers Arch       Date:  1990-01       Impact factor: 3.657

2.  Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.

Authors:  G A McPherson; J A Angus
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

3.  Inhibition of KATP channels in the rat tail artery by neurally released noradrenaline acting on postjunctional alpha2-adrenoceptors.

Authors:  Joy H Tan; Amr Al Abed; James A Brock
Journal:  J Physiol       Date:  2007-03-22       Impact factor: 5.182

4.  KATP-channel-induced vasodilation is modulated by the Na,K-pump activity in rabbit coronary small arteries.

Authors:  Marianne Glavind-Kristensen; Vladimir Matchkov; Vibeke Brogaard Hansen; Axel Forman; Holger Nilsson; Christian Aalkjaer
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

5.  Effects of pinacidil, RP 49356 and nicorandil on ATP-sensitive potassium channels in insulin-secreting cells.

Authors:  M J Dunne
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

6.  Comparison of the cromakalim antagonism and bradycardic actions of a series of novel alinidine analogues in the rat.

Authors:  J L Challinor-Rogers; T K Hay; G A McPherson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

7.  Effect of cromakalim and glibenclamide on spontaneous and evoked motility of the guinea-pig isolated renal pelvis and ureter.

Authors:  C A Maggi; S Giuliani; P Santicioli
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

8.  Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.

Authors:  K Satoh; H Yamada; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

9.  The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.

Authors:  V A Kreye; T Lenz; U Theiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

10.  Effects of glibenclamide on systemic and splanchnic haemodynamics in conscious rats.

Authors:  R Moreau; H Komeichi; P Kirstetter; S Yang; B Aupetit-Faisant; S Cailmail; D Lebrec
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.